Voyager Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 1.76 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 108.45M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer’s disease. The company also provides research program for the treatment of Huntington’s disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small mo...